Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Bayer to acquire AT-01 and AT-05 from Attralus, terms undisclosed
2d ago
Premium
The Fly
Bayer, Souffle Therapeutics report global licensing agreement for siRNA therapy
6d ago
Premium
The Fly
Barclays upgrades Bayer to Overweight on possible litigation overhang resolution
8d ago
Premium
The Fly
Bayer upgraded to Overweight from Equal Weight at Barclays
8d ago
Premium
The Fly
Bayer added to European Conviction List at Goldman Sachs
9d ago
Premium
The Fly
Bayer price target raised to EUR 41 from EUR 30.40 at Berenberg
30d ago
Premium
The Fly
Bayer price target raised to EUR 40 from EUR 34 at HSBC
1M ago
Premium
The Fly
Bayer upgraded to Overweight from Neutral at JPMorgan
1M ago
Premium
The Fly
Bayer initiates clinical trial with BAY 3401016
1M ago
Premium
The Fly
Bayer says Gadoquatrane met primary, secondary endpoints in trial
1M ago
Premium
The Fly
Bayer upgraded to Overweight from Equal Weight at Morgan Stanley
1M ago
Premium
The Fly
Bayer welcomes Solicitor General support for U.S. Supreme Court review
1M ago
Premium
The Fly
Bayer starts SUNFLOWER study
1M ago
Premium
The Fly
Bayer announces MEDRAD Centargo system secures 510(k) clearance
1M ago
Premium
The Fly
Dare Bioscience announces return of rights to Oveprene
1M ago
DARE
Premium
The Fly
Bayer data could ‘somewhat renew’ optimism for Bristol drug, says Morgan Stanley
2M ago
BMY
Premium
The Fly
Video: Biogen up after Novo weight-loss drug fails to slow Alzheimer’s progress
2M ago
MP
BMY
Premium
The Fly
Bayer’s Asundexian met primary efficacy, safety endpoints in Phase III study
2M ago
Premium
The Fly
Bayer announces FDA approval of Hyrnuo for non-small cell lung cancer
2M ago
Premium
The Fly
FDA grants accelerated approval to sevabertinib for non-squamous non-small cell
2M ago
Premium
Company Announcements
Bayer AG Announces Upcoming Financial Report Releases
2M ago
Premium
The Fly
Galmed’s Aramchol and Bayer’s Stivarga show synergistic effect in GI cancers
2M ago
GLMD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
